EA
ABBV icon

Everpar Advisors’s AbbVie ABBV Stock Holding History

Everpar Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Buy
6,863
+204
+3% +$43.9K 0.49% 42
2026
Q1 		$1.45M Buy
6,659
+377
+6% +$83.6K 0.5% 41
2025
Q4 		$1.44M Buy
6,282
+839
+15% +$191K 0.53% 39
2025
Q3 		$1.26M Buy
5,443
+609
+13% +$124K 0.5% 36
2025
Q2 		$897K Buy
4,834
+62
+1% +$11.5K 0.41% 45
2025
Q1 		$1,000K Buy
4,772
+163
+4% +$31.7K 0.53% 38
2024
Q4 		$819K Sell
4,609
-160
-3% -$29.4K 0.41% 49
2024
Q3 		$942K Buy
4,769
+51
+1% +$9.52K 0.49% 43
2024
Q2 		$809K Buy
4,718
+246
+6% +$40.8K 0.41% 54
2024
Q1 		$814K Sell
4,472
-1,635
-27% -$282K 0.5% 48
2023
Q4 		$946K Buy
+6,107
New +$890K 0.44% 64

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Everpar Advisors's ABBV Position: Q2 2026 in Review

Everpar Advisors increased its AbbVie (ABBV) stake by 3.1% in Q2 2026, buying an estimated $43.9K and bringing the position to 6,863 shares worth $1.73M. The position accounts for 0.49% of the portfolio, ranked #42.

Everpar Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Everpar Advisors held 6,863 shares of AbbVie worth $1.73M as of Q2 2026.
  • Everpar Advisors bought 204 AbbVie shares in Q2 2026, an estimated $43.9K.
  • AbbVie made up 0.49% of Everpar Advisors's portfolio in Q2 2026, its #42 holding.
  • Everpar Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.